GWM Advisors LLC
- SEC CIK
- 0001633516
- Latest filing
- Aug 12, 2026
GANX holding history
Gain Therapeutics, Inc. in every 13F filed by GWM Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
GANX overviewAll 13F holders of GANXFull Q2 2026 holdings
- Shares (Q2 2026)
- 10,600
- Value
- $21.5K
- % of portfolio
- <0.1%
- Quarters held
- 10
- Since Q1 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 10,600 | $21.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 10,600 | $20.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 10,600 | $34.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 10,600 | $18.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 10,600 | $19.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 10,600 | $20.2K | <0.1% | +10,600 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −225−100.0% | Sold out | Holders |
| Q1 2024 | 225 | $848 | <0.1% | +225 | New | Holders |
| Q4 2023 | 0 | $0 | 0.0% | −11,050−100.0% | Sold out | Holders |
| Q3 2023 | 11,050 | $36.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 11,050 | $49.5K | <0.1% | +550+5.2% | Added | Holders |
| Q1 2023 | 10,500 | $54.1K | <0.1% | +10,500 | New | Holders |